Reports confirm that Glenmark Pharmaceuticals has recently secured a final approval by the U.S. Food and Drug Administration (US FDA) for 400 mg and 800 mg Sevelamer Hydrochloride Tablets, which is a generic version of Genzyme Corporation’s Renagel Tablets, 400 mg and 800 mg. According …
Switzerland healthcare authorities approve Kerecis Omega3 Wound Kerecis plans to buy Phytoceuticals for establishing sales channel in Switzerland As of March 1, 2019, doctors would be able to prescribe Kerecis Omega3 Wound Kerecis, the firm which has pioneered tissue regeneration through fish skin, has …
These digital devices are the basis of Cognoa’s precision health platform. The FDA Breakthrough Device Program is envisioned to help patients in receiving timely access to advance technologies. Cognoa, Inc., the developer of AI-based personalized therapies and digital diagnostics, has reportedly announced that its first …
The latest takeover is in line with the strategy of Resonetics to add new manufacturing abilities. The financial terms of the acquisition are yet to be disclosed. The US-based laser micro manufacturing services provider Resonetics has reportedly purchased the contract medical device maker Caribou …
Pharmaceutical company Lupin has apparently launched the generic version of Clomipramine Hydrochloride capsules in the United States. Credible reports cite that these capsules have been introduced in the strengths of 25 mg, 50 mg, and 75 mg in the U.S. market. As per sources familiar …
The funding has been allotted by NASA Nebraska Space Grant, one of the 52 space grant consortiums in the U.S. Copper 3D, the Chilean/USA based 3D printing industry leader, has made it to the headlines for receiving a new grant from NASA. Reportedly, the Copper …
Senseonics Holdings, Inc., a US-based medical technology company, has reportedly announced the extension of its distribution agreement with Roche Diabetes Care based in Indianapolis, USA. The agreement has now been extended up to 31st of January 2021. As per the extended agreement, Senseonics will continue …
The latest transaction is the second significant collaboration by the two companies MeiraGTx Holdings Plc, a clinical-stage gene therapy company, has reportedly inked a strategic collaboration agreement with Janssen Pharmaceuticals, Inc., in a bid to develop and commercialize gene therapies for the IRD (inherited retinal …
Fexinidazole would add to the global efforts dedicated to eliminating sleeping sickness, a deadly neglected tropical disease, by 2020. The Democratic Republic of Congo exhibits the maximum incidence rate of sleeping sickness disease, with approximately 85 percent of recorded incidences. The Democratic Republic of Congo …
